HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 2005-0639v1 25/2/529    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, S. L. Articles by Merchav, S. Search for Related Content PubMed PubMed Citation Articles by Chan, S. L. Articles by Merchav, S.

TECHNOLOGY DEVELOPMENT

Enhanced In Vivo Homing of Uncultured and Selectively Amplified Cord Blood CD34⁺ Cells by Cotransplantation with Cord Blood-Derived Unrestricted Somatic Stem Cells

^aViaCell Singapore Research Centre, Singapore;
^bViaCell Inc., Cambridge, Massachusetts, USA

Key Words. Unrestricted somatic stem cell • Enhanced homing • CD34⁺ cells • Stromal-derived factor-1 knockdown

Correspondence: Shosh Merchav, Ph.D., M.B.A., Scientific Director, ViaCell Singapore Pte. Ltd., 1 Science Park Road, 02-09 The Capricorn, Singapore 117528, Singapore. Telephone: 65-68737874; Fax: 65-68733136; e-mail: Smerchav{at}viacellinc.com

Received December 20, 2005; accepted for publication October 18, 2006.
First published online in STEM CELLS EXPRESS   October 26, 2006.



Mesenchymal stem cells have been implicated as playing an important role in stem cell engraftment. Recently, a new pluripotent population of umbilical cord blood (UCB) cells, unrestricted somatic stem cells (USSCs), with intrinsic and directable potential to develop into mesodermal, endodermal, and ectodermal fates, has been identified. In this study, we evaluated the capacity of ex vivo expanded USSCs to influence the homing of UCB-derived CD34⁺ cells into the marrow and spleen of nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. USSCs induced a significant enhancement of CD34⁺ cell homing to both bone marrow and spleen (2.2 ± 0.3- and 2.4 ± 0.6-fold, respectively; p < .05), with a magnitude similar to that induced by USSCs that had been thawed prior to transplantation. The effect of USSCs was dose-dependent and detectable at USSC:CD34⁺ ratios of 1:1 and above. Enhanced marrow homing by USSCs was unaltered by extensive culture passaging of the cells, as similar enhancement was observed for both early-passage (passage 5 [p5]) and late-passage (p10) USSCs. The homing effect of USSCs was also reflected in an increased proportion of NOD/SCID mice exhibiting significant human cell engraftment 6 weeks after transplantation, with a similar distribution of myeloid and lymphoid components. USSCs enhanced the homing of cellular products of ex vivo expanded UCB lineage-negative (lin^–) cells, generated in 14-day cultures by Selective Amplification. The relative proportion of homing CD34⁺ cells within the culture-expanded cell population was unaltered by USSC cotransplantation. Production of stromal-derived factor-1 (SDF-1) by USSCs was detected by both gene expression and protein released into culture media of these cells. Knockdown of SDF-1 production by USSCs using lentiviral-SiRNA led to a significant (p < .05) reduction in USSC-mediated enhancement of CD34⁺ homing. Our findings thus suggest a clinical potential for using USSCs in facilitating homing and engraftment for cord blood transplant recipients.

This article has been cited by other articles:

				P. V. Guillot, O. Abass, J. H. D. Bassett, S. J. Shefelbine, G. Bou-Gharios, J. Chan, H. Kurata, G. R. Williams, J. Polak, and N. M. Fisk Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice Blood, February 1, 2008; 111(3): 1717 - 1725. [Abstract] [Full Text] [PDF]